Consumer Health Care Industry News Roundup
This article was originally published in The Tan Sheet
Executive Summary
More TiO2 Settlements Under Prop 65.
You may also be interested in...
TiO2-Containing Cosmetic Powders Subject Of Prop 65 Settlements
Five marketers of cosmetic powders containing titanium dioxide particles have agreed to settle with NGO the Public Interest Alliance LLC in a case brought under California’s Proposition 65 regulation.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.